Showing results (1-10 of 207) with videos related to
Sort By:
Pageof 21
Respiration; International Review of Thoracic Diseases|January 1, 1983
Exhausted platelets in chronic obstructive pulmonary diseaseG G Nenci, M Berrettini, T Todisco, et al.European Journal of Clinical Pharmacology|January 1, 1987
In vitro and ex vivo effects of indobufen on red blood cell deformabilityS Grasselli, R Guerciolini, V Iadevaia, et al.British Journal of Pharmacology|July 1, 1996
Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activationE Ribaldi, A M Mezzasoma, E Francescangeli, et al.Acta Haematologica|January 1, 1991
Generation of arachidonic acid metabolites from stimulated whole blood in patients with chronic myeloproliferative disordersP Parise, E Huybrechts, S Grasselli, et al.Biochemical Pharmacology|January 7, 1993
Cloricromene inhibits leukotriene formation by human polymorphonuclear leucocytes by suppressing arachidonate release from membrane phospholipidsP Gresele, E Ribaldi, A M Mezzasoma, et al.The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulationR Vezza, G G Nenci, P GreselePharmatherapeutica|January 1, 1981
Effect of pentoxifylline on platelet aggregationG G Nenci, P Gresele, G Agnelli, et al.Acta Medica Hungarica|January 1, 1990
Effects of the medium on the filterability of human red blood cellsP Tamás, P Gresele, D Polidori, et al.Blood|November 1, 1993
Prostaglandin E2 potentiates platelet aggregation by priming protein kinase CR Vezza, R Roberti, G G Nenci, et al.Trends in Pharmacological Sciences|April 1, 1991
Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic disordersP Gresele, H Deckmyn, G G Nenci, et al.Pageof 21